Literature DB >> 8671184

Leukaemia inhibitory factor significantly enhances the blastocyst formation rates of human embryos cultured in serum-free medium.

G F Dunglison1, D H Barlow, I L Sargent.   

Abstract

The aim of this study was to investigate the effect of leukaemia inhibitory factor (LIF) on human blastocyst formation rates in vitro. To do this, it was first necessary to devise a complex serum-free medium (CSFM) in which to test its activity. Blastocyst formation rates in CSFM microdrops (18.4%) showed no difference to those obtained previously for embryos cultured in 1 ml T6 medium containing 10% serum (25%). The majority of blastocysts were of optimal blastocyst grade (BG1/BG2) as compared to the poor grade (BG3). The percentage of BG1/BG2 blastocysts was decreased in CSFM microdrops (10.2%) compared to that observed in T6 medium (24.8%). Addition of 1000 IU/ml LIF to CSFM microdrops increased the blastocyst formation rate from 18.4 to 43.6% (P = 0.025) and increased the percentage of BG1/BG2 blastocysts (33%; P = 0.025) to levels comparable with those observed in T6 medium. Thus LIF significantly increased the quality and number of human blastocysts formed in CSFM medium, increasing the potential for blastocyst transfer in human in-vitro fertilization (IVF).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8671184     DOI: 10.1093/oxfordjournals.humrep.a019016

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  15 in total

1.  Clinical outcome of day 2 versus day 3 embryo transfer using serum-free culture media: a prospective randomized study.

Authors:  G Ertzeid; P O Dale; T Tanbo; R Storeng; E Kjekshus; T Abyholm
Journal:  J Assist Reprod Genet       Date:  1999-11       Impact factor: 3.412

Review 2.  The hamster as a model for embryo implantation: insights into a multifaceted process.

Authors:  Jeff Reese; Hehai Wang; Tianbing Ding; B C Paria
Journal:  Semin Cell Dev Biol       Date:  2007-12-04       Impact factor: 7.727

3.  Optimization of endometrial preparation results in a normal endometrial function test (EFT) and good reproductive outcome in donor ovum recipients.

Authors:  H J Kliman; S Honig; D Walls; M Luna; J C McSweet; Alan B Copperman
Journal:  J Assist Reprod Genet       Date:  2006-09-17       Impact factor: 3.412

4.  Effect of different concentrations of recombinant leukemia inhibitory factor on different development stage of mouse embryo in vitro.

Authors:  H D Tsai; C C Chang; Y Y Hsieh; L W Hsu; S C Chang; H Y Lo
Journal:  J Assist Reprod Genet       Date:  2000-07       Impact factor: 3.412

5.  Prolonged culture of human cryopreserved embryos with recombinant human leukemia inhibitory factor.

Authors:  Y Y Hsieh; H D Tsai; C C Chang; L W Hsu; S C Chang; H Y Lo
Journal:  J Assist Reprod Genet       Date:  2000-03       Impact factor: 3.412

6.  The presence of cytokines and growth factors in hydrosalpingeal fluid.

Authors:  Annika Strandell; Jane Thorburn; Ann Wallin
Journal:  J Assist Reprod Genet       Date:  2004-07       Impact factor: 3.412

7.  Population pharmacokinetic modelling of Emfilermin (recombinant human leukaemia inhibitory factor, r-hLIF) in healthy postmenopausal women and in infertile patients undergoing in vitro fertilization and embryo transfer.

Authors:  Timothy Goggin; Quyen T X Nguyen; Alain Munafo
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

8.  Developmental potential of isolated blastomeres from early mouse embryos in the presence and absence of LIF and GM-CSF.

Authors:  Behnaz Sheikholslami; Mojdeh Salehnia; Mojtaba Rezazadeh Valojerdi; Mehdi Ramezanzadeh
Journal:  J Assist Reprod Genet       Date:  2008-01-18       Impact factor: 3.412

Review 9.  Pertinence of apoptosis markers for the improvement of in vitro fertilization (IVF).

Authors:  D Haouzi; S Hamamah
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 10.  The role of growth factors and cytokines during implantation: endocrine and paracrine interactions.

Authors:  Ozlem Guzeloglu-Kayisli; Umit Ali Kayisli; Hugh S Taylor
Journal:  Semin Reprod Med       Date:  2009-02-05       Impact factor: 1.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.